Researchers develop ‘armored’ CAR-T with potential against solid tumors
Mouse model study uses PD-1 antibody technology from Eureka Therapeutics, which is also developing T-cell receptor therapies.
Startup gets $21M for monoclonal antibody that reaches inside the cancer cell
Most human monoclonal antibody therapies target proteins on the outer membrane of the cell – but a Bay Area startup is receiving a healthy flush of cash to further investigate its drug that reaches cancer cells on the inside. Cancer immunotherapy player Eureka Therapeutics has raised $21 million in a Series C financing round, led by […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.